| 000 | 01739 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516030111.0 | ||
| 264 | 0 | _c20110929 | |
| 008 | 201109s 0 0 eng d | ||
| 022 | _a1873-5835 | ||
| 024 | 7 |
_a10.1016/j.leukres.2011.02.015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGougounon, Alice | |
| 245 | 0 | 0 |
_aMinimally differentiated acute myeloid leukemia (FAB AML-M0): prognostic factors and treatment effects on survival--a retrospective study of 42 adult cases. _h[electronic resource] |
| 260 |
_bLeukemia research _cAug 2011 |
||
| 300 |
_a1027-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnthracyclines _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aCell Differentiation |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunophenotyping |
| 650 | 0 | 4 | _aKaryotyping |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aAbahssain, Halima | |
| 700 | 1 | _aRigollet, Lauren | |
| 700 | 1 | _aElhamri, Mohamed | |
| 700 | 1 | _aTigaud, Isabelle | |
| 700 | 1 | _aChelghoum, Youcef | |
| 700 | 1 | _aPlesa, Adriana | |
| 700 | 1 | _aDumontet, Charles | |
| 700 | 1 | _aMichallet, Mauricette | |
| 700 | 1 | _aThomas, Xavier | |
| 773 | 0 |
_tLeukemia research _gvol. 35 _gno. 8 _gp. 1027-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.leukres.2011.02.015 _zAvailable from publisher's website |
| 999 |
_c20669937 _d20669937 |
||